Duocarmycin TM (CBI-TMI) functions as a robust antitumor antibiotic with the capability to induce sequence-selective alkylation of duplex DNA. Its crucial role lies in serving as a cytotoxic payload during the development of antibody drug conjugates (ADCs). Reagent grade, for research purpose.
Usually ships within 24 hours.